FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / BMC Vet Res / Prevalence, risk factors, and characterisation of extended-s...
BMC veterinary research2024; 20(1); 412; doi: 10.1186/s12917-024-04260-z

Prevalence, risk factors, and characterisation of extended-spectrum β-lactamase -producing Enterobacterales (ESBL-E) in horses entering an equine hospital and description of longitudinal excretion.

Abstract: Extended-spectrum β-lactamase -producing Enterobacterales (ESBL-E) are important zoonotic pathogens that can cause serious clinical infections, also in horses. Preventing the spread of ESBL-E, especially in the equine hospital environment, is key to reducing the number of difficult-to-treat infections. Estimating the local prevalence of ESBL-E in horses is crucial to establish targeted infection control programs at equine hospitals. We conducted a prevalence and risk factor study in equine patients on admission to an equine teaching hospital in Finland through a rectal ESBL-E screening specimen of the horse and a questionnaire. Results: The prevalence of ESBL-E in admitted horses was 3% (5/161, 95% CI 1-7%); none of the tested factors remained statistically significant in multivariate analysis, although antimicrobial treatment within three months was borderline significant (p = 0.052). Extended-spectrum β-lactamase -producing Klebsiella pneumoniae ST6179:CTX-M-15 was detected in three horses using whole-genome sequencing, which in combination with patient records suggested nosocomial transmission. Escherichia coli isolates were ST1250:CTX-M-1 (n = 1), ST1079:CTX-M-1 (n = 1), and ST1245:CTX-M-14 (n = 1). Multiple virulence genes were detected in the ESBL-E isolates. In the ESBL-E positive horses enrolled in a one-year follow-up study, ESBL-E were unlikely to be isolated in rectal screening specimens after the initial positive specimen. Conclusions: The prevalence of ESBL-E in horses visiting a veterinary teaching hospital in Finland is low, indicating an overall low prevalence estimate in the country's equine population. No statistically significant risk factors were identified, likely due to the low number of cases. The duration of ESBL-E carriage is likely to be very short in horses.
© 2024. The Author(s).
Get Full Text
Publication Date: 2024-09-13 PubMed ID: 39272173PubMed Central: 5790241DOI: 10.1186/s12917-024-04260-zGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article pertains to an investigation into the prevalence, risk factors, and characteristics of certain antibiotic-resistant bacteria in horses, specifically extended-spectrum β-lactamase -producing Enterobacterales (ESBL-E). The study finds a low prevalence of ESBL-E in horses admitting to an equine hospital in Finland, with no significant risk factors identified due to the small number of cases.

Objective of the Study and Methodology

  • The primary objective of this research was to understand the prevalence, risk factors, and characteristics of ESBL-E in horses, especially in a hospital environment. This is crucial because ESBL-E is a significant zoonotic pathogen known to cause severe clinical infections. They are also resistant to many antibiotics, making them difficult to treat.
  • The study was conducted at an equine teaching hospital in Finland where equine patients were examined upon admission for the presence of ESBL-E. The researchers obtained rectal ESBL-E screening samples from the horses and used a questionnaire to gather data for the risk-factor study.

Findings

  • The prevalence of ESBL-E in admitted horses was found to be 3%, with none of the assessed factors showing a statistically significant relationship in a multivariate analysis. A relation was thought to exist with antimicrobial treatment within the last three months, but this was borderline significant with a p-value of 0.052.
  • Genome sequencing process exposed the presence of ESBL-E producing Klebsiella pneumoniae in three horses, suggesting a hospital-acquired transmission. Furthermore, they identified multiple virulence genes in the ESBL-E isolates.
  • Meanwhile, three types of ESBL-producing Escherichia coli isolates were found: ST1250: CTX-M-1, ST1079: CTX-M-1, and ST1245: CTX-M-14.
  • Positive ESBL-E horses were studied for a year to track the carrying duration, suggesting ESBL-E were unlikely to be isolated in rectal specimens after the initial positive specimen, implying that the duration of ESBL-E carriage in horses is short.

Conclusions

  • The research concluded that the prevalence of ESBL-E in visiting horses at a veterinary teaching hospital in Finland was low. This result suggested a low overall prevalence estimate in the country’s equine population.
  • No established risk factors were identified in this study, likely due to the low prevalence and therefore the small number of positive cases.
  • The research indicates that horses likely carry ESBL-E for a short period of time.

Cite This Article

APA
Eskola K, Aimo-Koivisto E, Heikinheimo A, Mykkänen A, Hautajärvi T, Grönthal T. (2024). Prevalence, risk factors, and characterisation of extended-spectrum β-lactamase -producing Enterobacterales (ESBL-E) in horses entering an equine hospital and description of longitudinal excretion. BMC Vet Res, 20(1), 412. https://doi.org/10.1186/s12917-024-04260-z

Publication

BMC veterinary research
ISSN: 1746-6148
NlmUniqueID: 101249759
Country: England
Language: English
Volume: 20
Issue: 1
Pages: 412

Researcher Affiliations

Eskola, Katarina
  • Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland. katarina.eskola@helsinki.fi.
Aimo-Koivisto, Elina
  • Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland.
Heikinheimo, Annamari
  • Department of Food Hygiene and Environmental Health, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland.
  • Food and Feed Microbiology Unit, Finnish Food Authority, Helsinki, Finland.
Mykkänen, Anna
  • Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland.
Hautajärvi, Tiina
  • Oy 4Pharma Ltd, Turku, Finland.
Grönthal, Thomas
  • Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland. thomas.gronthal@helsinki.fi.
  • Animal Health Diagnostics Unit, Finnish Food Authority, Helsinki, Finland. thomas.gronthal@helsinki.fi.

MeSH Terms

  • Animals
  • Horses
  • Horse Diseases / microbiology
  • Horse Diseases / epidemiology
  • beta-Lactamases / metabolism
  • beta-Lactamases / genetics
  • Prevalence
  • Risk Factors
  • Hospitals, Animal
  • Finland / epidemiology
  • Enterobacteriaceae Infections / veterinary
  • Enterobacteriaceae Infections / epidemiology
  • Enterobacteriaceae Infections / microbiology
  • Male
  • Female
  • Klebsiella pneumoniae / enzymology
  • Klebsiella pneumoniae / drug effects
  • Klebsiella pneumoniae / isolation & purification
  • Cross Infection / epidemiology
  • Cross Infection / veterinary
  • Cross Infection / microbiology
  • Escherichia coli / enzymology
  • Escherichia coli / isolation & purification
  • Enterobacteriaceae / enzymology
  • Enterobacteriaceae / isolation & purification
  • Enterobacteriaceae / drug effects
  • Anti-Bacterial Agents / pharmacology

References

This article includes 61 references
  1. Shnaiderman-Torban A, Navon-Venezia S, Dor Z, Paitan Y, Arielly H, Abu Ahmad W. Extended-spectrum β-lactamase-producing Enterobacteriaceae Shedding in Farm horses Versus hospitalized horses: prevalence and risk factors.. Anim (Basel) 2020;10(2):282.
    doi: 10.3390/ani10020282google scholar: lookup
  2. Walther B, Klein KS, Barton AK, Semmler T, Huber C, Wolf SA. Extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Acinetobacter baumannii among horses entering a veterinary teaching hospital: the contemporary trojan horse.. PLoS ONE 2018;13(1):e0191873.
    doi: 10.1371/journal.pone.0191873pubmed: 29381714pmc: 5790241google scholar: lookup
  3. Thomson K, Eskola K, Eklund M, Suominen K, Määttä M, Junnila J. Characterisation of and risk factors for extended-spectrum β-lactamase producing Enterobacterales (ESBL-E) in an equine hospital with a special reference to an outbreak caused by Klebsiella pneumoniae ST307:CTX-M-1.. Acta Vet Scand 2022;64(1):4.
    doi: 10.1186/s13028-022-00621-6pubmed: 35139865pmc: 8827190google scholar: lookup
  4. Loncaric I, Cabal Rosel A, Szostak MP, Licka T, Allerberger F, Ruppitsch W. Broad-spectrum cephalosporin-resistant Klebsiella spp. Isolated from diseased horses in Austria.. Anim (Basel) 2020;10(2):332.
    doi: 10.3390/ani10020332google scholar: lookup
  5. DebRoy C, Roberts E, Jayarao BM, Brooks JW. Bronchopneumonia Associated with Extraintestinal Pathogenic Escherichia Coli in a horse.. J Vet Diagn Invest 2008;20(5):661–4.
    doi: 10.1177/104063870802000524pubmed: 18776106google scholar: lookup
  6. Timoney PJ. Infectious diseases and International Movement of horses.. Equine Infect Dis 2014;544–551e1.
    doi: 10.1016/b978-1-4557-0891-8.00063-4google scholar: lookup
  7. Dominguez M, Münstermann S, de Guindos I, Timoney P. Equine disease events resulting from international horse movements: systematic review and lessons learned.. Equine Vet J 2016;48(5):641–53.
    doi: 10.1111/evj.12523pubmed: 26509734google scholar: lookup
  8. de Lagarde M, Fairbrother JM, Arsenault J. Prevalence. Risk factors, and characterization of Multidrug resistant and ESBL/AmpC producing Escherichia coli in healthy horses in Q, Canada, in 2015–2016.. Animals (Basel) 2020;10(3):523.
    doi: 10.3390/ani10030523google scholar: lookup
  9. de Lagarde M, Larrieu C, Praud K, Schouler C, Doublet B, Sallé G. Prevalence, risk factors, and characterization of multidrug resistant and extended spectrum β-lactamase/AmpC β‐lactamase producing Escherichia coli in healthy horses in France in 2015.. J Vet Intern Med 2019;33(2):902–11.
    doi: 10.1111/jvim.15415pubmed: 30648296pmc: 6430864google scholar: lookup
  10. Grönthal T, Österblad M, Eklund M, Jalava J, Nykäsenoja S, Pekkanen K. Sharing more than friendship – transmission of NDM-5 ST167 and CTX-M-9 ST69 Escherichia coli between dogs and humans in a family, Finland, 2015.. Eurosurveillance 2018;23(27):1700497.
    doi: 10.2807/1560-7917.ES.2018.23.27.1700497pubmed: 29991384pmc: 6152158google scholar: lookup
  11. Dolejska M, Duskova E, Rybarikova J, Janoszowska D, Roubalova E, Dibdakova K. Plasmids carrying blaCTX-M-1 and qnr genes in Escherichia coli isolates from an equine clinic and a horseback riding centre.. J Antimicrob Chemother 2011;66(4):757–64.
    doi: 10.1093/jac/dkq500pubmed: 21393204google scholar: lookup
  12. Huijbers PMC, de Kraker M, Graat EAM, van Hoek AHAM, van Santen MG, de Jong MCM. Prevalence of extended-spectrum β-lactamase-producing Enterobacteriaceae in humans living in municipalities with high and low broiler density.. Clin Microbiol Infect 2013;19(6):E256–9.
    doi: 10.1111/1469-0691.12150pubmed: 23397953google scholar: lookup
  13. Stull JW, Weese JS. Hospital-Associated infections in Small Animal Practice.. Vet Clin North Am Small Anim 2015;45(2):217–33.
    doi: 10.1016/j.cvsm.2014.11.009google scholar: lookup
  14. Hordijk J, Farmakioti E, Smit LAM, Duim B, Graveland H, Theelen MJP. Fecal carriage of extended-Spectrum-β-Lactamase/AmpC-Producing Escherichia coli in horses.. Appl Environ Microbiol 2020;86(8):e02590–19.
    doi: 10.1128/AEM.02590-19pubmed: 32033947pmc: 7117932google scholar: lookup
  15. Jalava J, Miettinen S, Pelkonen S, Rantala M. Prevalence of third-generation cephalosporin resistant Escherichia coli and their resistance mechanisms in dogs in Finland, P1107 abstract.. 22nd ECCMID Conference; 2012 Mar 31 – Apr 3; London, UK.
  16. Gröndahl-Yli-Hannuksela K, Lönnqvist E, Marttila H, Rintala E, Rantakokko-Jalava K, Vuopio J. Performance of the check-direct ESBL screen for BD MAXTM for detection of asymptomatic faecal carriage of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae.. J Glob Antimicrob Resist 2020;408–13.
    doi: 10.1016/j.jgar.2020.04.015google scholar: lookup
  17. Damborg P, Marskar P, Baptiste KE, Guardabassi L. Faecal shedding of CTX-M-producing Escherichia coli in horses receiving broad-spectrum antimicrobial prophylaxis after hospital admission.. Vet Microbiol 2012;154(3):298–304.
    doi: 10.1016/j.vetmic.2011.07.005pubmed: 21820821google scholar: lookup
  18. Johns I, Verheyen K, Good L, Rycroft A. Antimicrobial resistance in faecal Escherichia coli isolates from horses treated with antimicrobials: a longitudinal study in hospitalised and non-hospitalised horses.. Vet Microbiol 2012;159(3):381–9.
    doi: 10.1016/j.vetmic.2012.04.010pubmed: 22565010google scholar: lookup
  19. Baede VO, Wagenaar JA, Broens EM, Duim B, Dohmen W, Nijsse R. Longitudinal study of extended-Spectrum-β-Lactamase- and AmpC-Producing Enterobacteriaceae in Household Dogs.. Antimicrob Agents Chemother 2015;59(6):3117–24.
    doi: 10.1128/AAC.04576-14pubmed: 25779568pmc: 4432141google scholar: lookup
  20. Menezes J, Frosini SM, Belas A, Marques C, da Silva JM, Amaral AJ. Longitudinal study of ESBL/AmpC-producing Enterobacterales strains sharing between cohabiting healthy companion animals and humans in Portugal and in the United Kingdom.. Eur J Clin Microbiol Infect Dis 2023;42(8):1011–24.
    doi: 10.1007/s10096-023-04629-2pubmed: 37420129google scholar: lookup
  21. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.. Clin Microbiol Infect 2012;18(3):268–81.
    doi: 10.1111/j.1469-0691.2011.03570.xpubmed: 21793988google scholar: lookup
  22. Finnish Food Authority. FINRES-Vet 2022, Finnish Veterinary Antimicrobial Resistance Monitoring and Consumption of Antimicrobial Agents.. Finnish Food Authority publications 4/2023.
  23. Boyen F, Smet A, Hermans K, Butaye P, Martens A, Martel A. Methicillin resistant staphylococci and broad-spectrum β-lactamase producing Enterobacteriaceae in horses.. Vet Microbiol 2013;167(1):67–77.
    doi: 10.1016/j.vetmic.2013.05.001pubmed: 23759364google scholar: lookup
  24. Ewers C, Bethe A, Semmler T, Guenther S, Wieler LH. Extended-spectrum β-lactamase-producing and AmpC-producing Escherichia coli from livestock and companion animals, and their putative impact on public health: a global perspective.. Clin Microbiol Infect 2012;18(7):646–55.
    doi: 10.1111/j.1469-0691.2012.03850.xpubmed: 22519858google scholar: lookup
  25. Sadikalay S, Reynaud Y, Guyomard-Rabenirina S, Falord M, Ducat C, Fabre L. High genetic diversity of extended-spectrum β-lactamases producing Escherichia coli in feces of horses.. Vet Microbiol 2018;219:117–22.
    doi: 10.1016/j.vetmic.2018.04.016pubmed: 29778183google scholar: lookup
  26. Isgren CM, Edwards T, Pinchbeck GL, Winward E, Adams ER, Norton P. Emergence of carriage of CTX-M-15 in faecal Escherichia coli in horses at an equine hospital in the UK; increasing prevalence over a decade (2008–2017).. BMC Vet Res 2019;15(1):268.
    doi: 10.1186/s12917-019-2011-9pubmed: 31357996pmc: 6664770google scholar: lookup
  27. Mondal AH, Siddiqui MT, Sultan I, Haq QMR. Prevalence and diversity of blaTEM, blaSHV and blaCTX-M variants among multidrug resistant Klebsiella spp. from an urban riverine environment in India.. Int J Environ Health Res 2019;29(2):117–29.
    doi: 10.1080/09603123.2018.1515425pubmed: 30185065google scholar: lookup
  28. Corbella M, Caltagirone M, Gaiarsa S, Mariani B, Sassera D, Bitar I. Characterization of an outbreak of extended-spectrum β-Lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit in Italy.. Microb Drug Resist 2018;24(8):1128–36.
    doi: 10.1089/mdr.2017.0270pubmed: 29368992pmc: 6200023google scholar: lookup
  29. Von Salviati C, Friese A, Roschanski N, Laube H, Guerra B, Käsbohrer A. Extended-spectrum beta-lactamases (ESBL)/AmpC beta-lactamases-producing Escherichia coli in German fattening pig farms: a longitudinal study.. Berl Munch Tierarztl Wochenschr 2014;127(9–10):412–9.
  30. Kholik K, Srianto P, Aulanniam A, Abdul Rantam F, Madyawati SP. Characterization and phylogenetics of beta-lactamase Temoneira gene in Escherichia coli of the Bali cattle on Lombok island, Indonesia.. Iraqi J Vet Sci 2023;37(2):487–93.
    doi: 10.33899/ijvs.2022.135062.2441google scholar: lookup
  31. Li L, Wang B, Feng S, Li J, Wu C, Wang Y. Prevalence and characteristics of extended-spectrum β-Lactamase and plasmid-mediated Fluoroquinolone Resistance genes in Escherichia coli isolated from chickens in Anhui Province, China.. PLoS ONE 2014;9(8):e104356.
    doi: 10.1371/journal.pone.0104356pubmed: 25141348pmc: 4139264google scholar: lookup
  32. Walther B, Lübke-Becker A, Stamm I, Gehlen H, Barton AK, Janssen T. Suspected nosocomial infections with multi-drug resistant E. Coli, including extended-spectrum beta-lactamase (ESBL)-producing strains, in an equine clinic.. Berl Munch Tierarztl Wochenschr 2014;127(11–12):421–7.
    pubmed: 25872251
  33. Dor Z, Shnaiderman-Torban A, Kondratyeva K, Davidovich-Cohen M, Rokney A, Steinman A. Emergence and spread of different ESBL-Producing Salmonella enterica serovars in hospitalized horses sharing a highly transferable IncM2 CTX-M-3-Encoding plasmid.. Front Microbiol 2020;11:616032.
    doi: 10.3389/fmicb.2020.616032pubmed: 33391248pmc: 7773750google scholar: lookup
  34. Allen BL, Gerlach GF, Clegg S. Nucleotide sequence and functions of mrk determinants necessary for expression of type 3 fimbriae in Klebsiella pneumoniae.. J Bacteriol 1991;173(2):916–20.
    doi: 10.1128/jb.173.2.916-920.1991pubmed: 1670938pmc: 207091google scholar: lookup
  35. Gual-de-Torrella A, Delgado-Valverde M, Pérez-Palacios P, Oteo-Iglesias J, Rojo-Molinero E, Macià MD. Prevalence of the fimbrial operon mrkABCD, mrkA expression, biofilm formation and effect of biocides on biofilm formation in carbapenemase-producing Klebsiella pneumoniae isolates belonging or not belonging to high-risk clones.. Int J Antimicrob Agents 2022;60(4):106663.
    doi: 10.1016/j.ijantimicag.2022.106663pubmed: 35995073google scholar: lookup
  36. Butaye P, Stegger M, Moodley A, Damborg P, Williams A, Halliday-Simmonds I. One health genomic study of human and animal Klebsiella pneumoniae isolated at Diagnostic Laboratories on a small Caribbean Island.. Antibiot (Basel) 2021;11(1):42.
    doi: 10.3390/antibiotics11010042google scholar: lookup
  37. Wyres KL, Hawkey J, Hetland MAK, Fostervold A, Wick RR, Judd LM. Emergence and rapid global dissemination of CTX-M-15-associated Klebsiella pneumoniae strain ST307.. J Antimicrob Chemother 2019;74(3):577–81.
    doi: 10.1093/jac/dky492pubmed: 30517666google scholar: lookup
  38. Maddox TW, Pinchbeck GL, Clegg PD, Wedley AL, Dawson S, Williams NJ. Cross-sectional study of antimicrobial-resistant bacteria in horses. Part 2: risk factors for faecal carriage of antimicrobial-resistant Escherichia coli in horses.. Equine Vet J 2012;44(3):297–303.
    doi: 10.1111/j.2042-3306.2011.00440.xpubmed: 21848536google scholar: lookup
  39. Hippolis SH, Luke Hevostalous ry, Suomen Ratsastajainliitto ry. Hevostalous lukuina 2018.. .
  40. Varantola K, Launis V, Helin M, Spoof SK, Jäppinen S. Responsible conduct of research and procedures for handling allegations of misconduct in Finland. Guidelines of the Finnish Advisory Board on Research Integrity 2012.. Publications of the Finnish National Board on Research Integrity TENK 2013;p. 40.
  41. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals, CLSI standard VET01.. 2018;5th ed. Wayne, PA, USA.
  42. The European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters. Version 11.0.. .
  43. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals, CLSI supplement VET01S.. 2020;5th ed. Wayne, PA, USA.
  44. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing, CLSI supplement M100.. 2020;30th ed. Wayne, PA, USA.
  45. Babraham Bioinformatics. FastQC.. .
  46. Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data.. Bioinformatics 2014;30(15):2114–20.
    doi: 10.1093/bioinformatics/btu170pubmed: 24695404pmc: 4103590google scholar: lookup
  47. Souvorov A, Agarwala R, Lipman DJ. SKESA: strategic k-mer extension for scrupulous assemblies.. Genome Biol 2018;19(1):153.
    doi: 10.1186/s13059-018-1540-zpubmed: 30286803pmc: 6172800google scholar: lookup
  48. Feldgarden M, Brover V, Haft DH, Prasad AB, Slotta DJ, Tolstoy I. Validating the AMRFinder Tool and Resistance Gene Database by using Antimicrobial Resistance genotype-phenotype correlations in a Collection of isolates.. Antimicrob Agents Chemother 2019;63(11):e00483–19.
    doi: 10.1128/AAC.00483-19pubmed: 31427293pmc: 6811410google scholar: lookup
  49. Zankari E, Allesøe R, Joensen KG, Cavaco LM, Lund O, Aarestrup FM. PointFinder: a novel web tool for WGS-based detection of antimicrobial resistance associated with chromosomal point mutations in bacterial pathogens.. J Antimicrob Chemother 2017;72(10):2764–8.
    doi: 10.1093/jac/dkx217pubmed: 29091202pmc: 5890747google scholar: lookup
  50. Bortolaia V, Kaas RS, Ruppe E, Roberts MC, Schwarz S, Cattoir V. ResFinder 4.0 for predictions of phenotypes from genotypes.. J Antimicrob Chemother 2020;75(12):3491–500.
    doi: 10.1093/jac/dkaa345pubmed: 32780112pmc: 7662176google scholar: lookup
  51. Carattoli A, Zankari E, García-Fernández A, Voldby Larsen M, Lund O, Villa L. In Silico Detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing.. Antimicrob Agents Chemother 2014;58(7):3895–903.
    doi: 10.1128/AAC.02412-14pubmed: 24777092pmc: 4068535google scholar: lookup
  52. Malberg Tetzschner AM, Johnson JR, Johnston BD, Lund O, Scheutz F. In Silico Genotyping of Escherichia coli isolates for Extraintestinal virulence genes by Use of whole-genome sequencing data.. J Clin Microbiol 2020;58(10):e01269–20.
    doi: 10.1128/jcm.01269-20pubmed: 32669379pmc: 7512150google scholar: lookup
  53. Joensen KG, Scheutz F, Lund O, Hasman H, Kaas RS, Nielsen EM. Real-time whole-genome sequencing for routine typing, Surveillance, and outbreak detection of Verotoxigenic Escherichia coli.. J Clin Microbiol 2020;52(5):1501–10.
    doi: 10.1128/jcm.03617-13google scholar: lookup
  54. Joensen KG, Tetzschner AM, Iguchi A, Aarestrup FM, Scheutz F. Rapid and Easy in Silico Serotyping of Escherichia coli isolates by Use of whole-genome sequencing data.. J Clin Microbiol 2015;53(8):2410–26.
    doi: 10.1128/JCM.00008-15pubmed: 25972421pmc: 4508402google scholar: lookup
  55. Beghain J, Bridier-Nahmias A, Le Nagard H, Denamur E, Clermont O. ClermonTyping: an easy-to-use and accurate in silico method for Escherichia Genus strain phylotyping.. Microb Genom 2018;4(7):e000192.
    doi: 10.1099/mgen.0.000192pubmed: 29916797pmc: 6113867google scholar: lookup
  56. Larsen MV, Cosentino S, Rasmussen S, Friis C, Hasman H, Marvig RL. Multilocus Sequence Typing of Total-Genome-Sequenced Bacteria.. J Clin Microbiol 2020;50(4):1355–61.
    doi: 10.1128/jcm.06094-1157google scholar: lookup
  57. Snitkin ES, Zelazny AM, Thomas PJ, Stock F, Henderson DK, Palmore TN. Tracking a Hospital Outbreak of Carbapenem-Resistant Klebsiella pneumoniae with Whole-Genome Sequencing.. Sci Transl Med 2012;4(148):148ra116.
    doi: 10.1126/scitranslmed.3004129google scholar: lookup
  58. Zhou H, Liu W, Qin T, Liu C, Ren H. Defining and evaluating a Core Genome Multilocus sequence typing Scheme for whole-genome sequence-based typing of Klebsiella pneumoniae.. Front Microbiol 2017;8:371.
    doi: 10.3389/fmicb.2017.00371pubmed: 28337187pmc: 5340756google scholar: lookup
  59. Eskola K, Grönthal T, Heikinheimo A, Mykkänen A. Whole genome sequencing in extended-spectrum beta-lactamase (ESBL) producing Enterobacterales outbreak detection in an equine hospital.. Poster presented at: 13th International Meeting on Microbial epidemiological markers (IMMEM XIII). September 14–17 2022, Bath, United Kingdom.
  60. Eskola K, Grönthal T, Heikinheimo A, Mykkänen A. Whole genome sequencing in extended-spectrum beta-lactamase (ESBL) producing Enterobacterales outbreak detection in an equine hospital.. Poster presented at: Finnish Veterinary Congress 2022. November 2–4 2022, Helsinki, Finland.
  61. Kaira O. Laajakirjoisia beetalaktamaaseja tuottavat enterobakteerit hevosilla Suomessa.. University of Helsinki Open Repository: University of Helsinki; 2023.

Citations

This article has been cited 0 times.
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.